ACCESSION: MSBNK-SMB_Measured-HSA032P0353004
RECORD_TITLE: Uncharacterized; LC-ESI-QTOF; MS2; POSITIVE; Averaged data
DATE: 2025.04.02 (Averaged 2025.02.25, Processed 2025.02.25, Annotated 2025.03.31, Curated 2025.04.02)
AUTHORS: Shin-MassBank project
LICENSE: CC BY-NC-SA
PUBLICATION: Yu et al. Front Cell Infect Microbiol. 2022,11,763507
COMMENT: This is an averaged mass spectra data created by averaging product ion scan data obtained from the following DDA dataset.
COMMENT: REPOSITORY MetaboLights
COMMENT: DATASET_ID MTBLS3233
COMMENT: DATASET_TITLE The gut microbiome and metabolites are altered and interrelated in patients with rheumatoid arthritis
COMMENT: DATASET_AUTHORS Die Yu, Juping Du, Xia Pu, Liyuan Zheng, Shuaishuai Chen, Na Wang, Jun Li, Shiyong Chen, Shaobiao Pan, Bo Shen
COMMENT: MS1_M/Z_AVERAGED_THRES 15.000
COMMENT: MS2_M/Z_AVERAGED_THRES 20.000
COMMENT: DATASET_FILE_NUM 60
COMMENT: NUM_AVERAGED_SPEC 12
COMMENT: RAW_SPEC {'RA9-pos_4179': {'bp': 4743.0, 'sum': 5404.0}, 'HC21-pos_4329': {'bp': 3579.0, 'sum': 4343.0}, 'RA9-pos_4187': {'bp': 3095.0, 'sum': 3768.0}, 'HC21-pos_4318': {'bp': 2105.0, 'sum': 2869.0}, 'RA6-pos_4255': {'bp': 1994.0, 'sum': 3576.0}, 'RA2-pos_4638': {'bp': 1958.0, 'sum': 2569.0}, 'HC9-pos_4413': {'bp': 1719.0, 'sum': 2789.0}, 'HC9-pos_4401': {'bp': 1655.0, 'sum': 2369.0}, 'HC19-pos_4294': {'bp': 1053.0, 'sum': 1257.0}, 'HC7-pos_4417': {'bp': 956.0, 'sum': 1466.0}, 'HC19-pos_4306': {'bp': 930.0, 'sum': 1389.0}, 'HC4-pos_4463': {'bp': 304.0, 'sum': 406.0}}
COMMENT: RETENTION_TIME_STDEV 0.010
COMMENT: PRECURSOR_M/Z_RAW 353.136853
COMMENT: PRECURSOR_M/Z_STDEV 0.001031
COMMENT: PRECURSOR_IN_MS1 mz 353.139087; int 40.436; delta(ppm) 9.606755
COMMENT: PROPOSED_CHARGE_STATE +1; mz 354.142428; int 9.307; cor 0.979
COMMENT: PROPOSED_ISOTOPE_STATE ND
COMMENT: PROPOSED_ION_FORM M+H; M+Na; mz 375.121196; int 1.122; cor 0.717
COMMENT: PROPOSED_ION_FORM M+Na; M+2Na-H; mz 375.121196; int 1.122; cor 0.717
COMMENT: PROPOSED_MAX_NUM_S 0
COMMENT: PROPOSED_MF SevenGoldenRules 14.747; C14H24O10; [M+H]+; delta(ppm) -14.747321
COMMENT: PROPOSED_MF SevenGoldenRules 11.249; C18H26O3P2; [M+H]+; delta(ppm) -11.248631
COMMENT: PROPOSED_MF SevenGoldenRules 6.557; C20H21N2O2P; [M+H]+; delta(ppm) -6.557205
COMMENT: PROPOSED_MF SevenGoldenRules 0.176; C13H26N2O5P2; [M+H]+; delta(ppm) 0.176070
COMMENT: PROPOSED_MF SevenGoldenRules 1.931; C21H20O5; [M+H]+; delta(ppm) 1.931095
COMMENT: PROPOSED_MF SevenGoldenRules 4.867; C15H21N4O4P; [M+H]+; delta(ppm) 4.867496
COMMENT: PROPOSED_MF SevenGoldenRules 8.664; C14H25O8P; [M+H]+; delta(ppm) 8.664371
COMMENT: PROPOSED_MF SevenGoldenRules 13.356; C16H20N2O7; [M+H]+; delta(ppm) 13.355796
COMMENT: PROPOSED_MF SevenGoldenRules 12.485; C13H22N4O6; [M+Na]+; delta(ppm) -12.485241
COMMENT: PROPOSED_MF SevenGoldenRules 11.886; C23H23P; [M+Na]+; delta(ppm) -11.885513
COMMENT: PROPOSED_MF SevenGoldenRules 8.436; C12H26O10; [M+Na]+; delta(ppm) -8.435564
COMMENT: PROPOSED_MF SevenGoldenRules 4.704; C16H28O3P2; [M+Na]+; delta(ppm) -4.703925
COMMENT: PROPOSED_MF SevenGoldenRules 0.300; C18H23N2O2P; [M+Na]+; delta(ppm) 0.299864
COMMENT: PROPOSED_MF SevenGoldenRules 5.304; C20H18N4O; [M+Na]+; delta(ppm) 5.303653
COMMENT: PROPOSED_MF SevenGoldenRules 7.481; C11H28N2O5P2; [M+Na]+; delta(ppm) 7.481452
COMMENT: PROPOSED_MF SevenGoldenRules 9.353; C19H22O5; [M+Na]+; delta(ppm) 9.353330
COMMENT: PROPOSED_MF SevenGoldenRules 12.485; C13H23N4O4P; [M+Na]+; delta(ppm) 12.485241
COMMENT: PROPOSED_COMPOUND SIMILARITY:GNPS 25.000; LMBHKAWZFQGFAN-UHFFFAOYSA-N; C21H20O5; 3-(3,4-dihydro-2H-benzo[b][1,4]dioxepin-7-yl)-7-ethoxy-2-methyl-4H-chromen-4-one
COMMENT: PROPOSED_COMPOUND SIMILARITY:GNPS 1.000; ZXQHQUXJMNGVJP-UHFFFAOYSA-N; C19H22O5; NCGC00380167-01!3-(4-hydroxy-3-methoxyphenyl)propyl 3-(4-hydroxyphenyl)propanoate [IIN-based on: CCMSLIB00000845015]
COMMENT: PROPOSED_COMPOUND SIMILARITY:GNPS 1.000; JQNSUDIGIIGIOL-UHFFFAOYSA-N; C21H20O5; Massbank:PR310755 Isoflavone base + 2O, 1MeO, 1Prenyl
COMMENT: PROPOSED_COMPOUND SIMILARITY:GNPS 1.000; IDYQRTRHYWQKKY-UHFFFAOYSA-N; C21H20O5; methyl 2-(2-oxo-4-propylchromen-7-yloxy)-2-phenylacetate CollisionEnergy:102040
COMMENT: CONFIDENCE Level 5: Exact mass of interest 353.139030; Observed in MS1; Charge state +1;
CH$COMPOUND_CLASS: Uncharacterized
CH$FORMULA: C39H42O2
CH$EXACT_MASS: 542.318480
CH$SMILES: CCCC#Cc1cc(C#CCCC)cc(C#Cc2cc(C#CC(C)(C)C)c(cc2C#CC(C)(C)C)C2OCCO2)c1
CH$IUPAC: InChI=1S/C39H42O2/c1-9-11-13-15-30-25-31(16-14-12-10-2)27-32(26-30)17-18-33-28-35(20-22-39(6,7)8)36(37-40-23-24-41-37)29-34(33)19-21-38(3,4)5/h25-29,37H,9-12,23-24H2,1-8H3
CH$LINK: PUBCHEM CID:11353257
SP$SCIENTIFIC_NAME: Homo sapiens
SP$LINK: NCBI-TAXONOMY 9606 
SP$SAMPLE: Feces
AC$INSTRUMENT: UPLC system, AB SCIEX - TripleTOF 5600+ mass spectrometer, AB SCIEX
AC$INSTRUMENT_TYPE: LC-ESI-QTOF
AC$MASS_SPECTROMETRY: MS_TYPE MS2
AC$MASS_SPECTROMETRY: ION_MODE POSITIVE
AC$MASS_SPECTROMETRY: COLLISION_ENERGY 30 V
AC$MASS_SPECTROMETRY: ION_SPRAY_VOLTAGE 5.0 kV
AC$MASS_SPECTROMETRY: IONIZATION ESI
AC$MASS_SPECTROMETRY: MASS_ACCURACY MS1(ppm) 15.00; MS2(ppm) 20.00
AC$CHROMATOGRAPHY: COLUMN_NAME ACQUITY UPLC T3 column (1.8 Âµm, 100 mm x 2.1 mm; Waters)
AC$CHROMATOGRAPHY: FLOW_GRADIENT 0.0-0.5 min, 5% B; 0.5-7.0 min,` 100% B; 7.0-8.0 min, 100% B; 8.0-8.1 min, 5% B; 8.1-10.0 min, 5% B. 
AC$CHROMATOGRAPHY: FLOW_RATE 0.4 mL/min
AC$CHROMATOGRAPHY: RETENTION_TIME 4.999
MS$FOCUSED_ION: PRECURSOR_M/Z 353.139030
MS$DATA_PROCESSING: RECALIBRATE Data dependent recalibration using whole DDA dataset
PK$SPLASH: splash10-0002-0090000000-1269fd89306086824e4a
PK$ANNOTATION: m/z int annotation m/z_nocal m/z_std(ppm) int_std cor n
  297.0760021 999.0000 ? 297.077856 8.0350 0.00 0.6128 12
  353.1451126 96.2020 ? 353.146273 13.0711 45.90 1.0000 10
PK$NUM_PEAK: 2
PK$PEAK: m/z int. rel.int.
  297.076002 999.00 999
  353.145113 96.20 96
//
